Browse the evidence

Individualized nutritional rehabilitation, including whey protein (10g 3x/day), fish oil, and vitamin D supplementation combined with resistance training, significantly improves muscle strength, cognitive function, and quality of life in elderly patients with sarcopenia and cognitive impairment compared to standard care.

For elderly patients with both muscle loss and cognitive decline, a standard diet and exercise plan is often insufficient. A specialized program combining high-quality whey protein (10g, 3 times daily), Omega-3s with Vitamin D, and targeted resistance training, managed by a multidisciplinary team, significantly improves strength, thinking skills, and daily living ability. This approach requires more resources but yields superior functional outcomes for this vulnerable population.

Creatine supplementation increases fat-free mass (FFM) and lean body mass (LBM) only when combined with resistance training (RT); it produces no significant lean mass gains in non-resistance training contexts.

If your goal is to increase muscle mass, you must lift weights. Creatine will help you gain about 3.4 kg of lean mass if you train, but it will not build muscle if you only take the supplement without resistance exercise.

Combined lifestyle interventions integrating both dietary changes and structured exercise produce greater improvements in diabetes management (weight loss, glycemic control, cardiovascular risk) than either intervention alone.

Do not choose between diet and exercise; do both. Work with a healthcare provider to create a personalized plan that includes a balanced diet and at least 150 minutes of weekly exercise. This combination offers the best protection against complications and medication dependence.

Optimal combined SPAN behaviors (high sleep 8.0-9.4h, high MVPA 42-104min, high diet quality 57.5-72.5) are associated with a 57% lower risk of MACE compared to the lowest tertile of all behaviors.

To maximize cardiovascular protection, aim for 8-9.5 hours of sleep, 42-104 minutes of moderate-to-vigorous exercise daily, and a high-quality diet (score 32.5-50.0). This combination is associated with a 57% lower risk of major cardiovascular events compared to having low levels of all three behaviors.

Metabolic bariatric surgery (MBS) provides superior long-term weight loss and glycemic control compared to non-surgical management in patients with obesity and type 2 diabetes.

For patients with severe obesity and type 2 diabetes, metabolic bariatric surgery offers significantly better long-term weight loss and blood sugar control than non-surgical management. While surgery is not for everyone, those who undergo it maintain much greater weight loss (22% vs 8.6%) and better glycemic control over five years. If surgery is not an option, intensive lifestyle modification and pharmacotherapy are critical alternatives to mitigate health risks.

Obesity treatments (lifestyle, medications, surgery) improve obesity-related diseases, physical health-related quality of life (HrQoL), and body image, with the magnitude of benefit often correlating with the amount of weight loss.

Know that your treatment will likely improve your health conditions, energy, and how you feel about your body, even if weight loss is slow. Different treatments offer different benefits; for example, surgery and newer medications often provide greater health gains than lifestyle changes alone. Discuss with your provider which treatment best addresses your specific health concerns, such as heart disease or joint pain.

Mediterranean and plant-forward dietary patterns improve glycemic control and reduce type 2 diabetes risk more effectively than rigid single-nutrient prescriptions.

Adopt a Mediterranean or plant-forward eating style focusing on whole foods, fiber, and unsaturated fats. Avoid rigid 'diet' labels; prioritize long-term sustainability and individual metabolic response over short-term restriction.

Adequate fruit and vegetable intake (>5 days/week meeting ≥100g/day threshold) and a balanced meat-vegetable diet are protective against stroke, reducing risk by approximately 41-57% compared to low intake or vegan diets.

Eat more fruits and vegetables daily (aim for >100g each) and maintain a balanced diet that includes moderate amounts of meat. This combination is strongly associated with a significantly lower risk of stroke compared to low intake or strict vegan diets. Focus on variety and balance rather than extreme restriction.

Adherence to a Mediterranean diet reduces cardiometabolic risk by improving lipid profiles, lowering blood pressure, and enhancing insulin sensitivity.

Adopt a Mediterranean-style eating pattern by prioritizing plant-based foods, healthy fats like olive oil, and moderate protein from fish and poultry. This approach is linked to lower risks of heart disease and stroke. Focus on long-term adherence rather than strict calorie counting.

Combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists provides additive and synergistic benefits for Cardiovascular-Kidney-Metabolic (CKM) syndrome by targeting complementary mechanisms, resulting in superior glycemic control, weight loss, and organ protection compared to monotherapy.

If you have Type 2 Diabetes, Heart Failure, Kidney Disease, or Obesity, current medical guidelines strongly support using SGLT2 inhibitors and GLP-1 receptor agonists, either alone or together, to protect your heart and kidneys. These drugs work through different mechanisms to lower blood sugar, reduce weight, and protect organs. While they can be expensive and hard to access, they are considered first-line treatments for high-risk patients. Talk to your doctor about whether combination therapy is appropriate for your specific risk profile, especially if single medications aren't enough.

High-quality weight loss, defined as maximizing fat loss while preserving skeletal muscle mass, is critical for maintaining metabolic health, insulin sensitivity, and long-term weight maintenance.

When losing weight, prioritize strategies that protect your muscles, such as adequate protein intake and resistance exercise. Losing muscle along with fat can harm your metabolism and insulin sensitivity, making long-term weight maintenance harder.

Obesity is a modifiable risk factor for pancreatic cancer (PC), with a 5-unit BMI increase associated with an 8-12% rise in PC risk.

Maintaining a healthy weight, especially around the abdomen, is important for reducing your risk of pancreatic cancer. Obesity is linked to an 8-12% increase in risk for every 5-unit increase in BMI.

Intensive, multicomponent lifestyle intervention (diet, exercise, behavioral counseling) remains foundational and synergistic with anti-obesity medications (GLP-1 RAs), improving outcomes and mitigating side effects, whereas relying on medication alone without lifestyle support may lead to suboptimal results and higher discontinuation.

Do not skip lifestyle changes just because you are taking weight-loss medication. Combine your medication with a structured plan involving diet, exercise, and behavioral counseling. This approach maximizes your weight loss, helps you keep the weight off, and can reduce medication side effects like nausea. Aim for 200-300 minutes of moderate exercise per week and attend intensive counseling sessions (at least 12 in the first year).

Whey protein supplementation (20-40 g/day) combined with resistance training preserves lean body mass and improves strength during GLP-1RA-induced weight loss.

Aim for 1.2-2.0 grams of protein per kilogram of body weight daily. Use whey protein shakes (20-40g) to help meet this goal, especially if you struggle to eat enough solid food. Combine this with resistance training to protect your muscles.

Prevention of GLP-1RA-induced muscle loss requires a multimodal strategy combining resistance exercise, high protein intake (1.2-1.6 g/kg/day), and potentially specific supplements (BCAA, Creatine, Vitamin D).

To keep your muscles while losing weight on GLP-1s, lift weights 2-3 times a week and eat 1.2-1.6 grams of protein per kg of your body weight every day. Spread this protein across 3 meals. Consider adding creatine or Vitamin D if your diet is lacking.

Combining GLP-1 receptor agonists with resistance and aerobic exercise training yields greater fat loss and better preservation of lean muscle mass compared to GLP-1 use alone.

If you are prescribed a GLP-1 medication for weight loss, do not rely on the drug alone. You must combine it with resistance and aerobic exercise. This combination is critical to ensure you lose fat rather than muscle, preserving your metabolic health and physical function.

Combining GLP-1 receptor agonists with resistance training and/or specific nutritional strategies (e.g., higher protein, ketogenic therapy) preserves fat-free mass and muscle strength better than pharmacotherapy alone.

To prevent muscle loss while on GLP-1s, consider combining your medication with resistance training and a diet that supports muscle retention, such as one higher in protein or potentially ketogenic, under medical supervision.

Obesity medications (OMs) such as semaglutide and tirzepatide cause significant weight loss but also result in lean mass loss, necessitating targeted nutritional and exercise interventions to preserve skeletal muscle.

OMs like semaglutide and tirzepatide are highly effective for weight loss but can cause muscle loss. To counter this, eat enough protein (0.8-1.5 g/kg/day depending on your age/health) and do resistance exercises. This helps protect your muscle while you lose fat.

Collagen supplementation significantly enhances fat-free mass and muscle strength gains in healthy adults undergoing resistance training, outperforming whey protein and other protein sources.

If you are doing resistance training, adding collagen supplements can significantly boost your muscle mass and strength gains, potentially more than whey protein. You don't need to rely solely on high-BCAA proteins; collagen's unique amino acids support muscle structure and recovery. Aim for a daily dose that fits your diet, as the study shows benefits across various dosages.

GLP-1 receptor agonists (semaglutide, tirzepatide) produce significant weight loss (10-21%) but also reduce lean body mass, necessitating resistance training to preserve muscle and performance in physically active individuals.

If you are using GLP-1 agonists like semaglutide or tirzepatide for weight loss, expect to lose both fat and some muscle. To protect your strength and athletic performance, you must incorporate resistance training into your routine. This combination helps offset the lean mass loss associated with these drugs. Do not rely on the medication alone; long-term maintenance requires continuous therapy and lifestyle adherence, as stopping treatment typically leads to weight regain.

Multidisciplinary therapy combining nutritional, physical, and behavioral interventions reduces body weight, fat mass, and cardiometabolic risk factors in adults with obesity.

To manage obesity effectively, you need a team approach that includes diet, exercise, and behavioral counseling, rather than just one of these. Aim for sessions 2-3 times a week, lasting at least 20 minutes, over a period of weeks to months. This combined approach helps reduce weight and fat while preserving muscle and improving metabolic health, which is crucial for long-term success.

Aerobic and resistance exercise reduce hepatic steatosis and improve insulin sensitivity in MASLD patients independently of significant body weight loss.

You do not need to lose weight to improve your liver health through exercise. Both aerobic exercise (45-60 minutes, 3-5 times a week) and resistance training (3 times a week for 8-12 weeks) can significantly reduce liver fat and improve insulin sensitivity, even if your body weight remains stable. Focus on consistency and metabolic health rather than just the number on the scale.

Resistance exercise training (RET) volume is the primary driver of skeletal muscle hypertrophy, with higher weekly volumes yielding greater muscle growth up to a specific threshold.

To maximize muscle growth, focus on increasing your total training volume (sets x reps x weight) over time. You do not need to lift extremely heavy weights; moderate loads work just as well if you train close to failure. However, be aware that there is a limit to how much volume you can handle before gains stall or health suffers, so find your personal threshold.

Lifestyle interventions during OMM treatment should shift focus from caloric deficit for weight loss to optimizing health, specifically by mitigating lean mass loss through high protein intake and resistance training.

While taking OMMs, prioritize consuming 1.5g of protein per kg of fat-free mass (or 80-120g daily) and engage in resistance training 2-3 times per week. This helps preserve muscle mass and strength, which can be lost during rapid weight loss, and supports overall physical function.